0001562180-16-002653.txt : 20160616
0001562180-16-002653.hdr.sgml : 20160616
20160616171352
ACCESSION NUMBER: 0001562180-16-002653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160615
FILED AS OF DATE: 20160616
DATE AS OF CHANGE: 20160616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAUKOS Corp
CENTRAL INDEX KEY: 0001192448
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26051 MERIT CIRCLE
STREET 2: SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
BUSINESS PHONE: 949-367-9600
MAIL ADDRESS:
STREET 1: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
FORMER COMPANY:
FORMER CONFORMED NAME: GLAUKOS CORP
DATE OF NAME CHANGE: 20020925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calcaterra Chris M.
CENTRAL INDEX KEY: 0001640771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37463
FILM NUMBER: 161718241
MAIL ADDRESS:
STREET 1: C/O GLAUKOS CORPORATION
STREET 2: 26051 MERIT CIRCLE, SUITE 103
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-06-15
false
0001192448
GLAUKOS Corp
GKOS
0001640771
Calcaterra Chris M.
C/O GLAUKOS CORPORATION
20651 MERIT CIRCLE, SUITE 103
LAGUNA HILLS
CA
92653
false
true
false
false
Chief Commercial Officer
Common Stock
2016-06-15
4
M
false
33600.00
4.225
A
273600.00
D
Common Stock
2016-06-15
4
M
false
11864.00
7.275
A
285464.00
D
Common Stock
2016-06-15
4
S
false
45464.00
28.46
D
240000.00
D
Stock Options (Right to buy)
7.275
2016-06-15
4
M
false
11864.00
0.00
D
2024-07-10
Common Stock
11864.00
98136.00
D
Stock Options (Right to buy)
4.225
2016-06-15
4
M
false
33600.00
0.00
D
2023-01-29
Common Stock
33600.00
18400.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
This transaction was executed in multiple trades at prices ranging from $28.00 to $28.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vests equally for 12 months thereafter, such that the stock option will vest in full on July 31, 2016, the second anniversary of the grant date.
This option, which represented the right to purchase a total of 52,000 shares, has a four-year vesting schedule in which 25% vested on January 29, 2014, the first anniversary of the grant date, and the remainder vests equally for 36 months thereafter, such that the stock option will vest in full on July 31, 2017, the fourth anniversary of the grant date.
/s/ Richard L. Harrison, Attorney-in-Fact
2016-06-15